Led

"This might be an ignorant question, but it seems to me that if Resverlogix was to be acquired by a BP, that milestone payments would be moot"

I would agree with your first part, especially when apabetalone has proven to be safe by DSMB 9 times throughout the BOM Medical trial. Therefore I do not see how milestone payments would apply. BOM2 would only entail a Phase 3b trial. 

"maybe HL would have to pay some, but they would go to the BP that (hypothetically) acquired Resverlogix....Would they not?"

To your second part, I do not understand what you are questioning. 

Koo